Team:BostonU

From 2014.igem.org

(Difference between revisions)
Line 32: Line 32:
<li><a href="">PROJECT</a>
<li><a href="">PROJECT</a>
<ul>  
<ul>  
-
<li><a href="https://2014.igem.org/Team:BostonU/Chimera">Overview</a></li>  
+
<li><a href="https://2014.igem.org/Team:BostonU/Chimera">Overview</a></li>
 +
<li><a href="https://2014.igem.org/Team:BostonU/Encoder">Priority Encoder</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/MoClo">MoClo Assembly Method</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/MoClo">MoClo Assembly Method</a></li>  
                         <li><a href="https://2014.igem.org/Team:BostonU/Backbones">Low Copy Backbones</a></li>  
                         <li><a href="https://2014.igem.org/Team:BostonU/Backbones">Low Copy Backbones</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">Tandem Promoters</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">Tandem Promoters</a></li>
       <li><a href="https://2014.igem.org/Team:BostonU/FusionProteins">Fusion Proteins</a></li>  
       <li><a href="https://2014.igem.org/Team:BostonU/FusionProteins">Fusion Proteins</a></li>  
-
<li><a href="https://2014.igem.org/Team:BostonU/FlowCytometry">Flow Cytometry</a></li>  
+
      <li><a href="https://2014.igem.org/Team:BostonU/Repressors">Repressor Proteins</a></li>
 +
<li><a href="https://2014.igem.org/Team:BostonU/FlowCytometry">Software Tools</a></li>  
  </ul>
  </ul>
</li>  
</li>  
Line 45: Line 47:
<li><a href="https://2014.igem.org/Team:BostonU/Parts">Parts Submitted</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Parts">Parts Submitted</a></li>
             <li><a href="https://2014.igem.org/Team:BostonU/Workflow">Chimera Workflow</a></li>
             <li><a href="https://2014.igem.org/Team:BostonU/Workflow">Chimera Workflow</a></li>
-
<li><a href="https://2014.igem.org/Team:BostonU/Encoder">Priority Encoder</a></li>
 
             <li><a href="https://2014.igem.org/Team:BostonU/Medals">Medal Fulfillment</a></li>
             <li><a href="https://2014.igem.org/Team:BostonU/Medals">Medal Fulfillment</a></li>
             <li><a href="https://2014.igem.org/Team:BostonU/Future">Future Work</a></li>
             <li><a href="https://2014.igem.org/Team:BostonU/Future">Future Work</a></li>
Line 56: Line 57:
<li><a href="https://2014.igem.org/Team:BostonU/Protocols">Protocols</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/Protocols">Protocols</a></li>  
                         <li><a href="https://2014.igem.org/Team:BostonU/BackbonesNotebook">Backbones</a></li>  
                         <li><a href="https://2014.igem.org/Team:BostonU/BackbonesNotebook">Backbones</a></li>  
-
                         <li><a href="https://2014.igem.org/Team:BostonU/TandemPromoters">Tandem Promoters</a></li>
+
                         <li><a href="https://2014.igem.org/Team:BostonU/TandemPromoters">Tandem Promoters and Repressors</a></li>
                         <li><a href="https://2014.igem.org/Team:BostonU/FusionProteinsNotebook">Fusion Proteins</a></li>
                         <li><a href="https://2014.igem.org/Team:BostonU/FusionProteinsNotebook">Fusion Proteins</a></li>
  </ul>
  </ul>
   </li>
   </li>
<li><a href="">CONSIDERATIONS</a>
<li><a href="">CONSIDERATIONS</a>
-
    <ul>  
+
  <ul>  
<li><a href="https://2014.igem.org/Team:BostonU/Collaborations">Collaborations</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Collaborations">Collaborations</a></li>
 +
<li><a href="https://2014.igem.org/Team:BostonU/Measurement">Measurement Track</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Safety">Safety</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Safety">Safety</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/Interlab">Interlab Study</a></li>
<li><a href="https://2014.igem.org/Team:BostonU/NEGEM">NEGEM</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/NEGEM">NEGEM</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/HumanPractices">Policy and Practices</a></li>  
<li><a href="https://2014.igem.org/Team:BostonU/HumanPractices">Policy and Practices</a></li>  
-
  </ul>  
+
  </ul>
<li><a href="https://2014.igem.org/Team:BostonU/Acknowledgements">ACKNOWLEDGEMENTS</a>
<li><a href="https://2014.igem.org/Team:BostonU/Acknowledgements">ACKNOWLEDGEMENTS</a>
   </li>
   </li>

Revision as of 00:23, 15 October 2014



chimera - an optimized synthetic biology workflow

Currently in synthetic biology, the creation of novel genetic circuits revolves around a familiar design-build-test cycle. As an increasing number of laboratories become involved in designing newer and more sophisticated constructs, the lack of standardization in production and characterization inhibits workflow efficiency and, by extension, growth of the field. The 2014 Boston University iGEM team seeks to employ a formalized and optimized workflow supported by new bio-design automation applications, with the aim of benefiting synthetic biologists seeking to more efficiently design, build, and characterize complex constructs.

Advancements in bio-design automation (or BDA) have allowed for the implementation of a variety of software and automation tools that help improve the efficiency in a synthetic biology laboratory. We will take a novel approach to the design-build-test cycle by using software tools to formalize our workflows, thus making us one of the first BDA iGEM teams. We will supplement the CIDAR MoClo basic parts library (built by the 2012 and 2013 BU iGEM teams) with hybrid promoters, fusion proteins, and a variety of new destination vectors. With these modular parts, we will build complex constructs using our formalized workflow, in addition to providing comprehensive characterization data for all new parts and improving data for existing parts in the Registry of Standard Biological Parts.

Our BDA approach will include utilizing various software tools throughout the design-build-test cycle in our wet lab work, including Eugene, Raven, and the TASBE Tools for flow cytometry.

 

 


Our Sponsors